Assignment 202
Assignment 202
The International Council for Harmonization of Technical Requirements for Pharmaceuticals for
Human Use (ICH) is unique in bringing together the regulatory authorities and pharmaceutical
industry to discuss scientific and technical aspects of pharmaceuticals and develop ICH
guidelines. Since its inception in 1990, ICH has gradually evolved, to respond to increasingly
global developments in the pharmaceutical sector and these ICH guidelines are applied by a
growing number of regulatory authorities. ICH's mission is to achieve greater harmonization
worldwide to ensure that safe, effective and high quality medicines are developed, and registered
and maintained in the most resource efficient manner whilst meeting high standards. Since its
announcement of organizational changes in October 2015, ICH has grown as an organization and
now includes 20 Members and 36 Observers.
At the first ICH Steering Committee (SC) meeting of ICH the Terms of Reference were agreed
and it was decided that the Topics selected for harmonization would be divided into Safety,
Quality and Efficacy to reflect the three criteria which are the basis for approving and
authorizing new medicinal products. The birth of ICH took place at a meeting in April 1990,
hosted by EFPIA in Brussels. Representatives of the regulatory agencies and industry
associations of Europe, Japan and the US met, primarily, to plan an International Conference and
terms of reference of ICH. First decade saw significant progress in the development of Tripartite
ICH Guidelines on Safety, Quality and Efficacy topics. Work was also undertaken on a number
of important multidisciplinary topics, which included MedDRA (Medical Dictionary for
Regulatory Activities) and the CTD (Common Technical Document). For two decades the ICH
process has achieved much success. This success is attributed not only to a process of scientific
consensus developed between industry and regulatory experts, but also to the commitment of the
regulatory parties to implement the ICH Tripartite Harmonized Guidelines and
recommendations. Throughout the second decade the development of ICH Guidelines continued,
but with more attention given to the need to maintain already existing Guidelines as science and
technology continued to evolve. Entering into its third decade of activity, ICH's attention is
directed towards extending the benefits of harmonization beyond the ICH regions.
1. Dhirubhai Ambani
Dhirubhai Ambani faced many risks like leaving his country for
employment, risking his job to start a business, changing the
direction of his business from spices to yarn, entering into new
businesses like petrochemicals, etc. He achieved grand success
because of his risk taking ability.
2. Azim Premji
Murthy has been listed among the 12 greatest entrepreneurs of our time
by Fortune magazine. He has been described as the "father of the Indian
IT sector" by Time magazine and CNBC for his contribution
to outsourcing in India. In 2005, he co-chaired the World Economic
Forum in Davos, Switzerland.
5. Shiv Nadar
Shiv Nadar, 76, founded HCL Infosystems in 1976 with an investment
of a few thousand dollars, selling calculators and microcomputers. HCL
soon expanded to Singapore and the Far East, generating over 1 million
rupees in sales not long after its expansion. HCL has continued to grow,
making Nadar a billionaire worth over $24.5 billion.
Working as an employee made him realise that this was not what he was
meant to do. He, along with a few of his colleagues who shared similar
opinions on the passionless job, decided to quit and start their own
company.
The first venture Nadar and his partners established was MicroComp
Limited. This company was involved in manufacturing and selling
teledigital calculators. But the group harboured a greater goal.
Nonetheless, MicroComp was considered as a first step toward
achieving the bigger goal.
Lakshmi Mittal, in full Lakshmi Narayan Mittal, (born June 15, 1950,
Sadulpur, Rajasthan, India), Indian businessman who was CEO (2006–
21) of ArcelorMittal, the world's largest steelmaking company. In
the 1960s Mittal's family moved to Calcutta (Kolkata), where his father
operated a steel mill.
His great-grandson Kumar Mangalam Birla, 54, now runs the company
and commands a net worth of $14.3 billion.
8. Dilip Shanghvi
Dilip Shanghvi, 66, started Sun Pharmaceutical in 1982 with a meager 10,000
rupee investment, or approximately $200. As the son of a pharmaceutical
distributor, Shanghvi knew what he was doing. Today, through gradual
development and a series of acquisitions, that investment has grown revenue
in 2021 to $4.31 billion, making Sun Pharma India's largest pharmaceutical
company. Today, Shanghvi has a net worth of around $15 billion.
9. Karsanbhai Patel
Karsanbhai Khodidas Patel (born 1945, Ruppur, Patan, Gujarat) is an Indian
billionaire businessman, industrialist and founder of the Nirma group a company
with major business interests in cements, detergents, soaps and cosmetics. As of
2021 Forbes has listed his net worth at US$4.9 billion.[1] He has interests in
education, and founded leading pharmacy college (Nirma Institute of
Pharmacy)and a leading engineering college/ university .
Karsanbhai Patel started out mixing detergents, manufactured and packaged in the
10x12ft room of his house and selling handmade detergent powder door-to-door
on his bicycle while going to his workplace, which was 17km from his home.
At that time detergent powder and cake market was limited only to the premium
segment and was dominated by Multinational corporations (MNC) like Procter &
Gamble, Hindustan Lever
Karsanbhai Patel is one such example from Gujarat. He quit his full-time
government job to follow his dream. He is said to have gone door-to-door selling
detergent on his bicycle thereby turning the company into a formidable group.
Today, he is one of the richest businessmen from Gujarat with a net worth of $4.1
billion, according to Forbes.
10. Ardeshir Godrej